Corporate presentation
Logotype for Kimball Electronics Inc

Kimball Electronics (KE) Corporate presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Kimball Electronics Inc

Corporate presentation summary

10 Nov, 2026

Company profile and platform

  • Global EMS and medical CDMO provider serving complex, highly regulated industries; FY26 revenue was $1.4B, with 5,500+ employees.

  • Integrated capabilities span design and development, prototyping, NPI or transfer of work, manufacturing, testing, and aftermarket support.

  • Manufacturing footprint spans 11 locations across North America, Europe, and Asia, with an in-region operating focus.

  • EMS offerings include PCB and system assembly, capital equipment assembly, prototyping, and supply chain management; medical CDMO includes molding, cleanroom assembly, cold chain, and complex devices.

End markets

  • FY26 net sales mix: Automotive 46%, Medical 29%, and Industrial 25%.

  • Automotive strengths include electronic power steering and braking; vehicle electrification and rising electronic content support demand.

  • Medical portfolio covers respiratory care, diagnostics, surgical systems, drug delivery, patient monitoring, and imaging, with a focus on Class II and Class III devices.

  • Industrial markets include factory automation, off-highway equipment, clean energy, public safety, climate control, and smart energy management.

Strategic priorities and Helvoet

  • Portfolio actions include divesting Automation, Test & Measurement, closing the Tampa facility, elevating medical CDMO, and guiding for organic growth in FY27.

  • Helvoet acquisition closed July 1; its medical CDMO operations in Tilburg and Pune bring 585+ employees, precision molding, microfluidics, cleanroom assembly, and tooling capabilities.

  • Helvoet adds an EU and India footprint for global medtech programs and offers potential EMS pull-through; the acquisition is expected to be accretive to earnings.

  • Growth strategy prioritizes medical CDMO, drug delivery, scalable capabilities, and selective M&A; potential areas include cardiology, orthopedics, minimally invasive surgery, and surgical instruments.

  • A phased rebranding to Kimball Solutions began at selected locations in July 2026, with completion targeted for July 2027; a shareholder vote and proposed ticker change to KMBL were upcoming.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Kimball Electronics